Introduction
Carpometacarpal (CMC) joint osteoarthritis (OA) affects more than 26% of women and 13% of men between the ages of 71-100 years. 1 Basal thumb pain during activity, 2 decreased grip strength, 1 and decreased thumb motion 3 are symptoms reported by individuals affected with CMC OA. Limitations in functional performance can include difficulty writing, manipulating small objects, and carrying a 10-pound bundle. 1 Studies suggest that 70%-88% of occupational and physical therapists recommend the use of an orthosis when working with individuals with this diagnosis. 4 A systematic review on orthoses for thumb CMC OA reports that the overall purpose of orthotic wear for CMC joint OA is to stabilize the joint and prevent contracture while maintaining hand function. 5 Orthoses are effective to
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decrease pain and improve function. 6, 7 However, current research does not support one design of an orthosis as more effective and/or more favorable than another. 8 Sillem et al 8 recommend that the therapist provision of an orthosis be based on individual patient needs and personal factors. A survey of hand therapists who prescribe CMC orthoses reported that 90% of therapists surveyed believed that patient compliance to orthosis wear was related to patient personal factors. 4 Colditz 9 reported that immobilizing the thumb metacarpophalangeal (MCP) joint limits motion of that joint and that poor orthosis compliance may be related to the number of joints included in the device. Synovitis of the MCP with hyperextension of the interphalangeal joint is a reason for including the MCP joint in an orthosis. 10 Instability of the basal joint can cause instability of the more distal joints. 10 The unstable MCP joint may be stabilized by inclusion in the orthotic device. The aim of this study is to compare the effectiveness of a CMC orthotic device that includes the MCP joint to a static orthosis that does not include the MCP joint on pain and functional abilities of hand in women with thumb CMC OA.
Methods

Study design
We conducted a simple blind quasi-experimental trial. Informed consent was obtained from all participants, and procedures were conducted according to the Declaration of Helsinki and approved by the Local Ethical Committee of Comite de investigación biomédica de Andalucia. The study has been registered at ClinicalTrials.gov web site (NCT02780999).
Patients
Eighty-four patients, 71 females (mean AE standard deviation [SD] age, 60.1 AE 9.6 years) and 13 males (mean AE SD age, 40 AE 11 years), with thumb CMC OA were consecutively recruited from June 2013 to February 2016 at a hand rehabilitation clinic in Spain. The patients were referred from multiple hand surgeons. Inclusion criteria for this study were women older than 18 years diagnosed with CMC joint OA with a reported pain intensity during activities of daily living (ADLs) of up to 4 of 10 on the visual analog scale (VAS). The referring physician made the diagnosis of CMC OA based on radiographs. Patients were excluded from participation if they had a neurologic disorder affecting the upper limb; had received previous treatment for their hand problem in the last 6 months including an intra-articular joint injection to wrist, fingers, or thumb; had fractures or a significant hand injury or previous surgery to the wrist or hand; had hand or finger tenosynovitis and/or Dupuytren disease. We also excluded patients who did not complete Disabilities of the Arm, Shoulder and HanddSpanish version (DASHdSpanish) questionnaire, presented with hyperextension of the MCP joint, or if they did not sign the informed consent.
Instrument
A static hand-based orthosis (Ballena) that immobilizes both the CMC joint and MCP joint was one of the orthoses used in this study (Fig. 1) . The second orthotic device, designed by Colditz, was a modification of the short opponens orthosis (Fig. 2) . This orthosis immobilizes the CMC joint while allowing the MCP joint the freedom to flex and extend.
Protocol
A hand therapist blinded to the subjects' intervention took baseline measurements (DASH questionnaire and pain intensity measured with VAS line). Participants were introduced in an Excel database in order of arrival into 1 of 2 groups (group A: Ballena orthotic and group B: Colditz orthotic). The same low-temperature thermoplastic material was used for both orthoses (Orfit Colors NS; 2.0 mm, microperforated/Orfit Industries, Wijnegem, Belgium). The orthoses were custom fabricated for each patient's dominant hand by 1 hand therapy clinician experienced in orthopedic cases.
Both groups of patients received identical orthotic wearing instructions. Patients were asked to use the orthosis during the nighttime and also during daytime ADLs for 3-4 hours per day. Each patient was also provided with a data collection sheet to monitor treatment compliance. All patients were asked to report any discomfort when using the orthosis on the collection sheet and to the therapist. The orthosis was the only treatment intervention received by the participants. No therapeutic exercises, modalities, or other complementary treatments were offered to the patients to not interfere with measuring the effectiveness of the orthosis. Patients were contacted by telephone a week after they received the device and were asked about pain intensity during activities and orthosis compliance. Three months after first evaluation, participants were assessed again in the hand therapy clinic to collect final outcome measurements.
Outcome measures
The pretreatment outcome measure traditionally used in OA clinical trials, the DASH, 11 was used to measure functional ability, and the intensity of hand pain during activity was assessed with a VAS. 12 After pretreatment measurements, subjects were assigned by arrival order, into 1 of the 2 groups. The same assessor who took the pretreatment measurement, and who remained blinded to the treatment allocation of the subjects, performed post-treatment assessments 3 months after use of the orthosis. The testing protocol and assessment protocol were prepared according to the editorial form of medical publishing and CONSORT (CONsolidated Standards of Reporting Trials) publishing guidelines. 
Statistical analysis
Sample size and power calculations were performed before undertaking the study to determine the number of participants needed in each group with the ENE 3.0 software (GlaxoSmithKline, Universidad Autónoma, Barcelona, Spain). The calculations were based on detecting a mean difference of 20 mm minimally clinically important difference on a 100-mm VAS assuming an SD of 20 mm, 14 a 2-tailed test, an alpha level of 0.05, and a desired power of 80%. The estimated desired sample size was 40 individuals per group. Data were analyzed using SPSS, version 21.0 (SPSS, Inc, Chicago, IL), conducted after an intention-to-treat analysis using the last value forward method. Group data were summarized using means and SDs. The Kolmogorov-Smirnov test was used to confirm the normality of the distribution of the data.
Comparison of baseline characteristics and outcome variables was performed with use of a 2-tailed independent t test for the continuous variable of age and baseline scores. Paired Student t tests were used to determine the statistical significance of the differences between the pre-and post-treatment measurements of the individual groups. A 2 Â 2 repeated-measures analysis of variance was used to determine the differences in time (preintervention and postintervention) as the within-subjects factor and group (Ballena or Colditz orthotic) as the between-subjects factor. The main hypothesis of interest was group Â time interaction. Between-group differences were expressed as mean differences with 95% confidence intervals. In all analyses, P < .05 was considered statistically significant. 
Results
Ninety-one consecutive subjects with thumb CMC OA were screened for eligibility criteria. Eighty-four patients (mean age, 60.1 AE 9.6 years; 91.7% females) satisfied all eligibility criteria and agreed to participate. The reasons for ineligibility included trauma (n ¼ 3), declined (n ¼ 3), and clinical signs of nerve root compression (n ¼ 1). Forty-four patients were assigned to the Ballena group and the other 40 patients to the Colditz group. Table 1 provides a flow diagram of subject recruitment and retention through the study. None of the subjects had modified the regular pharmacologic therapy during the study. No patients reported skin damage from the orthosis at phone call follow-up at 1 week, and all patients reported that they had been wearing the device as prescribed by the therapist. There was not a statistically significant difference between the control and intervention group regarding the subject demographics (Table 2) .
Hand pain intensity (VAS)
The mean pain score reported during activity decreased from 81 to 56 in the Ballena group and 72 to 47 in the Colditz group, and both groups achieved a clinically important difference. VAS scores revealed a significant effect of time (F [1.0] ¼ 413.327; P ¼ .001) but not for the group-by-time interaction (F [1.0] ¼ 0.075; P ¼ .8) for pain intensity. The post hoc analysis revealed both statistically and clinically significant within-group differences for the Ballena and Colditz groups (both P < .001; Table 3 ).
Response to treatment
The DASH score decreased from 53 to 42 in the Ballena group and 48 to 36 in the Colditz group, and both groups achieved a minimally clinically important difference. Outcome for DASH demonstrated a significant time factor (F [1.0] ¼ 211.742; P ¼ .001) and group-by-time interaction (F [1.0] ¼ 7.248; P ¼ .09). The post hoc analysis revealed both clinically and statistically significant differences between the baseline and 3 months for outcome score for the Ballena and Colditz groups (both P < .001; Table 3 ).
Discussion
The main purpose of this quasi-experimental clinical trial was to compare the effect of 2 different thermoplastic thumb orthoses: the Ballena orthotic with MCP joint included and the Colditz orthotic with MCP joint excluded. Immobilizing the thumb base is the treatment of choice in the conservative approach of thumb CMC OA. There is high to moderate evidence to support the use of CMC orthoses to decrease hand pain and improve hand function, but different orthoses have been described in the literature as a conservative intervention, and in most cases, orthotic interventions were accompanied by other medical treatments. 6, [15] [16] [17] [18] Used as a single intervention, this study provides evidence that each orthosis demonstrated the ability to reduce pain and improve function. Whether the MCP joint was included in the orthosis, at the 3 months of follow-up, both orthoses had the same effect on pain intensity. Our findings of a reduction in activity pain levels with the use of both orthoses are comparable to findings as reported by Weiss et al 19 and
McKee and Eason-Klatt. 20 The biomechanical findings of our study agree with the conclusions of other studies where no significant differences in pain were found using different orthoses. 5, 6, 15 However, regarding functional ability, according to our results, the Colditz orthotic with MCP joint excluded, demonstrated a 7-point better DASH score at 3 months of follow-up. It could be because it requires less immobilization and allows patients to perform ADL more efficiently. Previous investigations have reported that pain relief is correlated with improvements in functional activities, 21 and both groups in our trial had improved functional scores and demonstrated a reduction in pain. Weiss et al, 22 at 2004, using a prefabricated orthotic with MCP joint included, supported that the stabilization effect may reduce the pain at this joint. No comparisons on stabilization effects between different orthoses have been found. We could assume that greater stabilization results in less pain, but our study did not demonstrate that including the MCP joint had a greater effect on reducing pain intensity. Sillem et al 8 found small differences between 2 orthoses' effects on hand function (the Comfort Cool and the Hybrid orthosis), but we cannot compare their results with ours because the orthoses we used were different, as well as the assessment tool because they used the AUSCAN (Australian/Canadian Osteoarthritis Hand Index) questionnaire to evaluate hand function. The present study adds to our clinical knowledge base regarding the benefits of 2 different thumb orthoses used as a single intervention, on pain reduction and functional improvement in 3 months of follow-up in adults with CMC joint OA. As there was no significant statistical difference on pain relief achieved by including or not including the MCP joint in the device, we recommend that therapists need to take into consideration patient comfort and preference before making the final decision regarding orthotic design. Therapists much also take into consideration the appropriate design for a patient that presents with MCP hyperextension that can develop in patients with advanced stages of CMC OA. Our patient population did not include patients with MCP hyperextension, so the need to stabilize the MCP joint for these patients was not an issue. Perhaps, the orthosis with the MCP joint excluded could be more efficient for patients. Future studies should evaluate the stabilizing effect on the thumb caused by the immobilization of trapeziometacarpal excluding MCP joint and its positive effects on dexterity. Future study is needed to determine the appropriate orthotic choice for patients who present with MCP hyperextension. The effects of the orthoses that include or exclude the support at the MCP joint should be examined with patients with advanced stages of CMC OA.
There are a number of limitations to this study that must be considered. Only 1 therapist performed all interventions so the generalizability of the results may be limited. The follow-up period was limited to 3 months, and therefore, we cannot be certain if the pain reduction lasted beyond that time. In addition, we did not consider the number of years from diagnosis of CMC OA and the presence of bilateral symptoms or the occupation of patients. We also did not have a true control group. Future randomized clinical trials should include a control group, include multiple therapists, randomize patients to treatment groups, and collect data at a longterm follow-up.
Conclusion
Our quasi-experimental study suggests the efficacy of the Ballena or Colditz orthosis in the conservative treatment of individuals who present without MCP hyperextension in conjunction with thumb CMC OA. A clinically significant reduction in pain intensity and improvement in functional abilities was achieved with both orthoses. The immobilization of the MCP joint in the Ballena orthosis may restrict thumb dexterity. Future studies are needed to determine the most appropriate orthosis design for individuals who present with MCP hyperextension.
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